Device manufacturer, as written on reports
Cook Ireland: medical device reports filed with FDA
9,278 reports name it as the manufacturer of the device involved, 2008–2026.
- 9,278
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 587
- reports, 12 months to August 2026
- 762 in the 12 months before
- 63.1%
- classified as malfunction
- 62.3% across all reports
- 0.3%
- classified as death, as reported
- 0.9% across all reports
9,278 medical device reports received by FDA give Cook Ireland as the manufacturer of the device involved, 0% of the MAUDE database, from May 2008 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
587 reports arrived in the 12 months to August 2026, down 23% from 762 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (63.1%), injury (36.6%) and death (0.3%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Zilver Ptx Drug-Eluting Peripheral Stent | Stent, superficial femoral artery, drug-eluting | 723 | 9 | 0% |
| Zimmon Biliary Stent | Stents, drains and dilators for the biliary ducts | 657 | 45 | 0% |
| Evolution Biliary Controlled-Release Stent - Fully Covered | Stents, drains and dilators for the biliary ducts | 586 | 99 | 0.2% |
| Zilver Ptx 35 Drug-Eluting Stent | Stent, superficial femoral artery, drug-eluting | 581 | 16 | 0.7% |
| Echotip Ultra Endoscopic Ultrasound Needle | Biopsy needle | 571 | 49 | 0% |
| Echotip Procore High Definition Ultrasound Biopsy Needle | Biopsy needle | 544 | 27 | 0% |
| Zimmon Biliary Stent Set | Stents, drains and dilators for the biliary ducts | 526 | 34 | 0% |
| Zilver 635 Biliary Self Expanding Metal Stent | Stents, drains and dilators for the biliary ducts | 352 | 13 | 0% |
| EchoTip ProCore Endobronchial HD Biopsy Needle | Biopsy needle | 295 | 40 | 0% |
| Cotton-Leung Biliary Stent | Stents, drains and dilators for the biliary ducts | 260 | 20 | 1.1% |
| Resonance Stent Set | Stent, ureteral | 254 | 16 | 1.2% |
| Zimmon Pancreatic Stent | Stents, drains and dilators for the biliary ducts | 208 | 6 | 0% |
| Zilver Vena Venous Self-Expanding Stent | Stent, iliac vein | 198 | 9 | 0% |
| Evolution Duodenal Controlled-Release Stent - Uncovered | Stent, metallic, expandable, duodenal | 197 | 5 | 0.5% |
| Zilver Flex 35 Vascular Self-Expanding Stent | Stent, iliac | 195 | 23 | 0.5% |
| Evolution Biliary Controlled-Release Stent - Uncovered | Stents, drains and dilators for the biliary ducts | 193 | 20 | 0% |
| Echotip Ultra Endobronchial Hd Ultrasound Needle | Biopsy needle | 191 | 24 | 0% |
| Evolution Esophageal Controlled-Release Stent - Partially Covered | Prosthesis, esophageal | 152 | 6 | 0.6% |
| Evolution Colonic Controlled-Release Stent - Uncovered | Stent, colonic, metallic, expandable | 142 | 5 | 0.7% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| FGE | Stents, drains and dilators for the biliary ducts | 3,920 | 42.3% |
| FCG | Biopsy needle | 1,806 | 19.5% |
| NIU | Stent, superficial femoral artery, drug-eluting | 1,416 | 15.3% |
| NIO | Stent, iliac | 453 | 4.9% |
| ESW | Prosthesis, esophageal | 418 | 4.5% |
| FAD | Stent, ureteral | 288 | 3.1% |
| QAN | Stent, iliac vein | 240 | 2.6% |
| KNS | Unit, electrosurgical, endoscopic (with or without accessories) | 199 | 2.1% |
| MUM | Stent, metallic, expandable, duodenal | 199 | 2.1% |
| MQR | Stent, colonic, metallic, expandable | 153 | 1.6% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Cook Ireland reports
How many FDA device reports name Cook Ireland as manufacturer?
9,278 reports through August 2026, 587 of them in the latest 12 months.
Which of its brands appear most often?
Zilver Ptx Drug-Eluting Peripheral Stent (723), Zimmon Biliary Stent (657), Evolution Biliary Controlled-Release Stent - Fully Covered (586), Zilver Ptx 35 Drug-Eluting Stent (581) and Echotip Ultra Endoscopic Ultrasound Needle (571).
Which device types does it report on?
stents, drains and dilators for the biliary ducts (42.3%), biopsy needle (19.5%), stent, superficial femoral artery, drug-eluting (15.3%) and stent, iliac (4.9%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.